Loading viewer...
earnings
Format: PDF earnings
Q1 2023 quarterly earnings presentation dated May 9, 2023, reporting net sales of $349.7 million with mixed segment performance across Hardware Solutions, Robotics and Digital Solutions, and Protective Solutions. The company faced headwinds from supply chain costs and competitive market pressures while maintaining adjusted EBITDA of $40.2 million and positive free cash flow.
investor_presentation
48 Pages
earnings
138 Pages
Commonwealth Bank of Australia
Teva Pharmaceutical Q2 2023 Earnings Results
earningsearnings
54 Pages
Teva Pharmaceutical Industries Ltd.
Valmont Industries 2020 Full Year Earnings Presentation
earningsearnings
40 Pages
Valmont Industries, Inc.